Literature DB >> 3719114

Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells.

L L Wei, B S Katzenellenbogen, D W Robertson, D M Simpson, J A Katzenellenbogen.   

Abstract

We have prepared two analogs of the antiestrogen tamoxifen that incorporate known DNA-crosslinking functions, a chloroethyl nitrosourea and a nitrosocarbamate moiety, and we have tested their bioactivities in cultures of human breast cancer cells. Both compounds bind to the estrogen receptor from MCF-7 cells, with relative binding affinities of 0.18% for the nitrosocarbamate derivative and 0.35% for the nitrosourea derivative, while the affinity of tamoxifen is 1.8%, and that of estradiol is set at 100%. The tamoxifen-nitrosocarbamate compound demonstrated a dose-related cytotoxicity by the colony formation and cell proliferation assays that was not blocked by estradiol in either estrogen receptor-positive MCF-7 cells or estrogen receptor-negative MDA-MB-231 cells, and thus, was not studied further. Tamoxifen-nitrosourea (TAM-NU) showed dose-related cytotoxicity in MCF-7 cells that was blocked by estradiol, whereas its activity in MDA-MB-231 cells was unaffected by estradiol. N-2-(4-t-butylphenoxy)ethyl-N'-chloroethyl-N'-nitrosourea (BPE-NU), a control compound which contains the nitrosourea moiety but does not bind to the estrogen receptor, had no effect on cell proliferation or colony formation in MCF-7 cells, but was very inhibitory in the receptor-negative MDA-MB-231 cells. In contrast, TAM-NU was more active in the receptor-positive MCF-7 cells than in the MDA-MB-231 line. Thus, because TAM-NU appears to be active selectively against the receptor-positive cell line, and because this activity is suppressible by estradiol, its cytotoxic effect seems to be mediated via the estrogen receptor. However, since TAM-NU is active only in prolonged treatment protocols, it appears likely that its cytotoxic activity results from the hormone antagonistic effect of the hydrolysis product of TAM-NU (bis-desmethyltamoxifen), rather than from a direct receptor-mediated, DNA-directed cytotoxic action of TAM-NU itself. This study stresses the need for the use of appropriate control compounds and cell systems in order to assess whether the toxic activity displayed by hormone-cytotoxic conjugates is mediated by receptor interactions and whether it operates through the intended toxic mechanism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3719114     DOI: 10.1007/bf01806792

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  23 in total

1.  Synthesis of steroidal nitrosoureas with antitumor activity.

Authors:  H Y Lam; A Begleiter; G J Goldenberg; C M Wong
Journal:  J Med Chem       Date:  1979-02       Impact factor: 7.446

2.  Reports from the Workshop on the Use of Steroids as Carriers of Cytotoxic Agents in Breast Cancer: Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute.

Authors: 
Journal:  Cancer Treat Rep       Date:  1978-08

3.  Differential response by human melanoma cells to 1,3-bis-(2-chloroethyl)-1-nitrosourea and bleomycin.

Authors:  S C Berranco; B Drewinko; R M Humphrey
Journal:  Mutat Res       Date:  1973-08       Impact factor: 2.433

Review 4.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

5.  Differential growth inhibition of cultured mammalian cells: comparison of clinical antitumour agents and amsacrine derivatives.

Authors:  W R Wilson; S M Tapp; B C Baguley
Journal:  Eur J Cancer Clin Oncol       Date:  1984-03

6.  Carrier-dependent and carrier-independent transport of anti-cancer alkylating agents.

Authors:  J E Byfield; P M Calabro-Jones
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

Review 7.  Drug interaction with estrogen receptors for the control of breast neoplasia (review).

Authors:  G Leclercq; J C Heuson
Journal:  Anticancer Res       Date:  1981       Impact factor: 2.480

Review 8.  Dynamics of steroid hormone receptor action.

Authors:  B S Katzenellenbogen
Journal:  Annu Rev Physiol       Date:  1980       Impact factor: 19.318

9.  Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.

Authors:  W J Bodell; M Gerosa; T Aida; M S Berger; M L Rosenblum
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

10.  Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay.

Authors:  N Tanigawa; Y Mizuno; T Hashimura; K Honda; K Satomura; Y Hikasa; O Niwa; T Sugahara; O Yoshida; D H Kern
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

View more
  2 in total

1.  Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU).

Authors:  B Hartley-Asp; P I Christensson; K Gunnarsson; P O Gunnarsson; G Jensen; J Polacek; A Stamvik
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850

2.  Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.

Authors:  S B Sobottka; M R Berger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.